| Name | Title | Contact Details |
|---|
Sportsdigita is an American technology firm founded in 2011, headquartered in Minneapolis, Minnesota.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Founded in 2010, Infer delivers predictive business applications that help companies win more customers. It leverages proven data science to rapidly model the untapped data sitting in enterprises, along with thousands of external signals from the web. Customers include several large businesses and numerous high growth companies like AdRoll, Cloudera, New Relic, Nitro, SurveyMonkey, Tableau, Xactly and Zendesk. Headquartered in Palo Alto, California, Infer is funded by leading investors, including Redpoint Ventures, Andreessen Horowitz, Social and Capital Partnership, Sutter Hill Ventures and Nexus Venture Partners.
Deploy enterprise-ready PostgreSQL on your choice of platform and infrastructure with commercial support from Crunchy Data.
Commercial Real Estate Software that Delivers Guaranteed Reductions in Energy Spend & Improvements to Net Operating Income.